Search

everythinglearnresearchcommunity

for

Search:↓

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Stopping the use of fluocinolone oil containing balsam fragrance improved hair regrowth in children allergic to it.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Different hair loss types need accurate diagnosis for proper treatment.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Azathioprine may help treat severe alopecia areata, but more research is needed.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.